What sector does Tenet Health belong to?

Tenet Health operates in the Health Care sector, specifically the Health Care Facilities industry, and is listed on the US markets.

What is the current share price of THC?

As of the latest available quote, THC traded at $263.69. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of THC?

Tenet Health has a price-to-earnings (P/E) ratio of about 10.19. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of THC?

The market capitalisation of Tenet Health is approximately $40.29B.

Is Tenet Health profitable?

For its latest reported financial year, Tenet Health recorded a net profit margin of about 11.11%.

Does THC pay a dividend?

Tenet Health does not currently show a dividend yield in our data.

What is the return on equity (ROE) of THC?

Tenet Health has a return on equity (ROE) of about 50.82%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of THC?

Over the past 52 weeks, THC has traded between a low of $157.58 and a high of $283.05.

Tenet Health

THC US Health Care Health Care Facilities

S&P 400

$263.69

+0.09%

Delayed · cached 15 min

Fair value analysis

THC

Tenet Health

$263.69

Close used for this calculation

$352.76Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

77/100

Profitability21/25

Returns18/25

Balance Sheet19/25

Efficiency19/25

Growth20/25

Strong

Quality radar

Consensus fair value

$352.76

Below FV

▲ +33.8% against the close used

Model range $139.10 – $622.03

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$139.10Fair value$352.76Bull$622.03

FairClose

52-week traded range

52W low $161.3752W high $280.77

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Tenet Health closed at $263.69, 25.2% below the consensus fair value of $352.76 drawn from 8 valuation models.

Financial DNA score 77/100 — Strong. P/E of 17.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

$328.63

+24.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

$139.10

-47.2%

√(22.5 × EPS × BVPS)

EPS=15.49, BVPS=55.51 · outside Graham range (P/E 17, P/B 4.8) — asset-light, treat as a rough floor

P/E Fair Value

$309.80

+17.5%

EPS × 20x (sector P/E)

EPS=15.49, Sector P/E=20x

Peter Lynch (PEG)

$464.70

+76.2%

EPS × Growth% (PEG = 1 is fair)

EPS=15.49, g=30%

EV/EBITDA

$514.88

+95.3%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=4.37B

Book Value (P/B)

$622.03

+135.9%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=55.51, ROE=50.8%, g=6%, r=10%

Reverse DCF

$263.69

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 5% | Historical: 40%

Margin of Safety

$194.38

-26.3%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=259.18, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer